Yeah it’s ridiculous….
The quarterly states that they will submit their final submission to the FDA this quarter incorporating the requested changes to the proposed phase 3 trial by the FDA.
On track to commence phase 3 trials by end of year, that announcement should put a rocket under the share price.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $20.86M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 34.0¢ | $9.58K | 27.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11600 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 6296 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| TRP (ASX) Chart |